查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1847202

歐洲牙科移植骨替代物市場：市場規模、佔有率和趨勢分析（2025-2031 年）

Dental Bone Graft Substitute Market Size, Share & Trends Analysis | Europe | 2025-2031 | Includes: Allografts, Xenografts, Synthetics, Dental Growth Factors & Dental Barrier Membranes
出版日期: | 出版商: iData Research Inc. | 英文 260 Pages | 商品交期: 最快1-2個工作天內

價格
如有價格方面的疑問請按下「詢問」鍵來信查詢

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年歐洲牙科移植骨替代物和其他生醫材料市場價值約 3.55 億歐元。預計到 2031 年將達到近 4.5 億歐元，複合年成長率為 3.4%。

本報告涵蓋牙移植骨替代物（DBGS）、牙齒生長因子、牙齒屏障膜（DBM）、局部抗菌牙周治療、牙軟組織再生。 DBGS包括同種異體移植、異質骨移植和複合材料，但不包括自體移植，因為自體移植取自患者自身組織，目前尚無商業化產品。牙齒生長因子類別包括士卓曼集團旗下Emdogain®的銷售數據。 DBM市場分為可吸收型與不可吸收型兩大類。牙軟組織再生產品分為再生產品和創傷護理產品。

這反映了歐洲人口老化、植入數量不斷成長以及臨床醫生和患者對再生牙科的廣泛認知。該地區嚴格的同種異體移植規範、部分國家持續使用自體移植材料以及長期無牙患者數量減少促使口腔衛生狀況逐步改善，都抑制了市場需求。儘管存在這些不利因素，但異質骨移植和合成材料的穩定應用，以及屏障膜和軟組織產品的日益普及，預計將支撐市場在2031年之前保持持續成長。

市場概覽

再生牙科材料是歐洲現代植入和牙周治療的基石。 DBGS（牙科生物材料）支持齒槽窩保存、上顎竇提升、齒槽嵴增高和牙周缺損修復。牙科屏障膜引導組織再生並保護植體部位。局部牙周抗菌治療可清除殘留細菌，而軟組織產品則促進植入和植骨周圍的癒合。

西歐、北歐、中歐和南歐的需求情況各不相同。在植入市場成熟且自費模式較為完善的國家，異質骨移植和可吸收膠原蛋白膜更為普遍。同時，在文化偏好限制動物性產品或成本效益是主要促進因素的國家，合成生物生醫材料仍然十分重要。由於加工技術和品質保證的改進，同種異體移植在某些市場正在成長，但由於監管和組織庫整合等原因，其整體應用率低於美國。

人口老化仍然是一個結構性因素。預計到2030年，65歲及以上人口將佔歐洲總人口的約四分之一。老年人牙齒脫落、齒槽骨吸收和牙周炎的發生率較高，因此在植入前進行植骨的需求也較大。同時，廣泛的預防性牙科保健和口腔衛生習慣的改善，使許多人群的牙齒狀況得到改善，從而減緩了完全無牙病例的長期成長。這些因素共同作用，有利於再生性手術與植入和複雜牙周治療的持續發展。

市場價值不僅反映手術量，還取決於材料配置、病例複雜程度和訓練強度。優質異質骨移植和可吸收膜是兩階段和即時植入流程中的常規材料。對於偏好非動物源材料或需要特定吸收特性的診所，合成樹脂提供了更大的靈活性。軟組織產品和創傷護理有助於傷口縫合，尤其是在使用薄型生物材料或早期癒合階段需要額外保護的情況下。

市場促進因素

口腔疾病的盛行率

根據全球疾病負擔分析，重度牙周炎和無牙顎病例總數呈現上升趨勢。在西歐，2021年約有6,000萬人患有重度牙周炎，500萬人患有無牙頜，預計到2050年，患病率和發病率都將進一步增加。關於無牙頜，2021年西歐報告的病例數為3700萬例，到2050年將增至4800萬例，同期發病率也將上升。這種疾病負擔意味著對再生治療的持續臨床需求，包括拔牙窩的保存、垂直和水平齒槽嵴的形成以及最終修復前的軟組織穩定。

人口老化

預計到2030年，65歲及以上人口將佔歐洲人口的約25%。與老齡化相關的骨骼重塑以及糖尿病和骨質疏鬆症等全身性危險因子的高發，增加了植入治療前後進行植骨的可能性。因此，在尋求固定修復的老年患者中，骨吸收墊（DBGS）和生物膜的使用率可能會繼續保持在較高水準。

消費者意識和投資組合捆綁

隨著植入的普及，植入供應商和經銷商正將再生材料產品組合與植入線捆綁銷售。專業的銷售團隊和臨床教育計畫正在提高人們對膜在引導骨再生和可預測治療效果中的作用的認知。這種市場推廣模式推動了對異質骨移植、複合材料和可吸收膠原蛋白膜的需求，這些材料已成為植入植入的標準輔助材料。

同種異體移植材料的接受度不斷提高

隨著製造商實施有效的加工流程、可追溯性和品質保證措施，先前人們對疾病傳播的擔憂已有所緩解。更清晰的安全性和監管合規訊息促使更多臨床醫生考慮使用同種異體移植來治療特定類型的缺損，前提是其操作和重塑特性與手術相符。雖然同種異體移植的使用率仍低於美國，但在與組織庫建立緊密夥伴關係並接受系統培訓的中心，其接受度正在不斷提高。

市場限制

改善口腔衛生

日常口腔衛生、氟化物塗抹和預防保健降低了長期無牙症的發生率。隨著人口老化，人們的牙齒狀況趨於自然，全植入植牙和廣泛的根麵增容手術的絕對數量有所下降，但單顆植牙和節段植牙仍然很普遍。

繼續依賴自體移植材料

自體骨移植仍在繼續，尤其是在歐洲部分地區，外科醫生的偏好和報銷機制更傾向於選擇口腔內供體部位。在法國等骨移植材料相對不發達的市場，這種情況尤其明顯。自體骨移植正在取代商業性骨移植材料在水平和垂直骨增量手術中的需求，從而限制了同種異體骨、異質骨移植和複合材料的市場成長。

整合嚴格的同種異體移植通訊協定和組織庫

歐洲對人體組織產品的監管非常嚴格。過去十年，日益嚴格的監管增加了組織庫的營運成本，導致一些國家的組織庫關閉。例如，在葡萄牙，由於組織庫無法根據更新後的要求進行重組，同種異體移植的供應被迫停止。結果，核准的供應商數量減少，產品選擇範圍縮小，自體移植和經濟實惠的合成材料逐漸被採用，平均售價被限制，同種異體移植的使用率也隨之下降。

中歐和南歐部分地區的價格敏感性

許多植入病例由私人醫生承擔費用。在私人醫療支出較高的地區，臨床醫生可能更傾向於選擇性價比高的合成材料，或僅在臨床上最必要的情況下才使用膜材料。這將導致價格敏感型市場中高階產品組合的成長緩慢。

目標市場和數據範圍

  • 量化指標：市場規模、市佔率、預測、成長率、銷售量、平均售價。
  • 質性通報：公司概況、產品系列、顛覆性技術、影響再生醫學需求的疾病概述。
  • 時限：基準年 2024 年，預測至 2031 年，歷史資料（2021-2023 年）。
  • 資料來源：對產業領導者的直接訪談、政府和監管資料、醫院和私人診所的投入、進出口記錄、iData Research 內部資料庫。
  • 方法：收入模型為單位乘以平均售價，並透過手術量、病例組合和經銷商回饋檢驗。

目標市場及區隔

牙科移植骨替代物（DBGS）

  • 類型：同種異體移植、異質骨移植、複合移植
  • 用途：齒槽窩保存、上顎竇加強、齒槽嵴加強、牙周應用

牙齒生長因子

包括EMDOGAINR的銷售額

牙科屏障膜（DBM）

  • 類型：可吸收膜、不可吸收膜

局部牙周抗菌治療

牙科軟組織創傷護理

  • 類型：牙科創傷護理產品，如再生產品、牙塞、膠帶、泡棉等。

對於每個區隔市場提供市場價值、銷售、平均售價、成長率和企業市場占有率，以及截至 2021 年的銷售業績和截至 2031 年的預測數據。

競爭分析

2024年，蓋斯特利希（Geistlich）將繼續保持其在歐洲DBGS和整體生醫材料市場的領先地位。這項優勢源自於其在DBGS和DBM兩大領域的領先地位。在DBGS領域，蓋斯特利希憑藉其成熟的Bio-Oss®產品系列，在異質骨移植材料市場佔主導地位。在生物膜領域，Bio-Gide®因其易於操作、生物相容性和再形成性而被廣泛用作可吸收膠原蛋白屏障。博蒂斯生物生醫材料）憑藉其臨床驗證的成功案例、培訓記錄和長期穩定的業績，繼續成為牙周病醫生和植入醫生的首選。

博蒂斯生物材料公司預計在2024年將佔第二大市場。其關鍵優勢在於與士卓曼集團的戰略夥伴關係，後者持有博蒂斯30%的股份。這項合作關係將博蒂斯的再生產品與士卓曼在歐洲植入的領先地位結合，從而提升了產品可近性和聯合行銷的有效性。其旗艦產品包括TheraBone®（異質骨移植）和Maxgraft®（同種移植材料），為臨床醫生提供涵蓋不同材料偏好和適應症的豐富產品組合。

PerioChip® 是歐洲局部抗菌牙周治療市場的領先競爭者，在 2024 年的 DBGS 和生醫材料類別中排名第三。其分銷網路範圍廣泛。在歐洲，PerioChip® 由 Dexcel Pharma 透過德國、英國、比荷盧經濟聯盟、奧地利等地的子公司和合作夥伴進行銷售，在義大利由 Curaden Healthcare 銷售，在瑞士由 Karr Denta 銷售。 PerioChip® 可有效降低牙周袋內的細菌負荷，從而完善牙周組織的再生和維護通訊協定，因此在專科診所中得到廣泛應用。

其他區域和本地供應商正在與合成 DBGS、不可吸收膜和特定軟組織產品競爭，但市場仍然集中在那些能夠支持教育、臨床證據和可靠的物流，並能跨越多個監管要求不同的歐洲國家的公司。

科技與臨床趨勢

  • 根據適應症選擇合適的材料：臨床醫生通常會將異質骨移植用於維持空間，並與同種移植材料或複合材料結合使用，以加快重建速度，具體取決於病例目標和植入植入時間。
  • 轉向可吸收膜：由於使用方便且無需手術取出，可吸收膠原蛋白膜仍是大多數引導性骨再生（GBR）手術的首選。不可吸收膜則繼續用於需要更大空間維持的複雜垂直增容手術。
  • 屏障固定和穩定性：縫合系統、縫合技術和輪廓塑造的進步減少了微動，改善了軟組織管理，提高了對複雜缺陷的可預測性。
  • 軟組織重點：人們對增厚植入周圍的軟組織越來越感興趣，促使在活體組織切片組織較薄的患者或不宜採集自體結締組織的患者中，軟組織移植替代物和創傷護理材料的使用量增加。
  • 培訓、數位化規劃和工作流程：數位化規劃工具和教育項目著重於缺陷分類、移植物選擇和手術時機。統一的方案使多中心機構和轉診網路能夠標準化治療結果。
  • 品質系統和可追溯性：文件記錄、批次追蹤和無菌保證有助於增強臨床醫生對國家指南的信心和遵守，尤其是在使用同種異體移植方面。

地區

本分析重點在於歐盟（EU）。

本報告的目的

異質骨移植、同種移植、複合材料、屏障膜和軟組織產品領域中，規模最大、成長最快的商機在哪裡？

到 2031 年，人口老化和口腔疾病負擔將如何影響治療需求？

嚴格的同種異體移植法規和組織庫整合將如何影響歐洲市場的產品取得和定價？

對於植入和再生牙齦移植而言，最有效的教育和產品組合推廣策略是什麼？

Geistlich、Botiss Biomaterials 和 PerioChip® 等領導企業如何定位？它們的產品組合對 DBGS 和膜領域的競爭對手意味著什麼？

在哪些方面，對自體移植的依賴將繼續限制DBGS的採用，以及合成膜和靶向膜的選擇將如何滿足臨床需求。

哪些技術和工作流程趨勢將提高垂直和水平義肢、義肢接受腔保存和軟組織管理的可預測性？

如何協調培訓、庫存和病例記錄，以實現多中心診所和轉診網路結果的標準化？

iData Research 的「歐洲牙科移植骨替代物和其他生醫材料市場報告」透過程序感知模型、企業市場占有率分析和定價詳情來回答這些問題，以幫助您量化需求、規劃您的投資組合策略、指南區域市場進入，並優先考慮教育，以支持可預測的再生結果。

目錄

圖表清單

圖表列表

歐洲牙科移植骨替代物及其他生醫材料市場概覽

競爭分析

市場趨勢

市場趨勢

流程分段

市場區隔

重要報告更新

版本歷史記錄

調查方法

全球關稅的影響

歐洲牙科移植骨替代物及其他生醫材料市場概覽

  • 介紹
    • 牙科骨移植替代材料的應用
    • 牙科移植骨替代物的種類
    • 牙科生長因子產品
    • 牙膜
    • 抗菌牙周治療
    • 牙軟組織再生
  • 外匯
  • 市場概況及趨勢分析
  • 推動和阻礙因素
  • 競爭市佔率分析
  • 併購

國家概況

  • 介紹
    • 人口
    • 人均GDP
    • 價格指數
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 比荷盧經濟聯盟
  • 斯堪地那維亞
  • 奧地利
  • 瑞士
  • 葡萄牙

程式編號

  • 歐洲牙齒脫落統計數據
    • 齒槽骨移植手術
    • 人工植牙手術和DBGS滲透率
    • 目的性牙骨頭移植術

牙科骨移植替代物市場

  • 介紹
    • 自體移植
    • 同種異體移植
    • 異種移植
    • 合成纖維
  • 市場概覽
  • 市場分析與預測
    • 牙科骨移植替代物市場總規模
    • 同種異體移植市場（依區隔市場分類）
    • 異種移植市場
    • 合成市場
    • 依手術類型分類的牙科骨移植替代材料銷售情況
  • 推動和阻礙因素
  • 競爭市佔率分析

牙科生長因子市場

  • 介紹
  • 市場分析與預測
  • 推動和阻礙因素

牙科屏障膜市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 牙科屏障膜市場
    • 可吸收牙科屏障膜市場
    • 不可吸收牙科屏障膜市場
  • 計數分析
    • 牙科屏障膜單元（依尺寸）
  • 推動和阻礙因素
  • 競爭市佔率分析

區域抗菌牙周病治療市場

  • 介紹
  • 市場分析與預測
  • 推動和阻礙因素
  • 競爭市佔率分析

牙科軟組織再生市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 牙科軟組織再生市場
    • 牙科創傷護理市場
  • 推動和阻礙因素
  • 競爭市佔率分析

簡稱

Product Code: iDATA_EUDBGS25_MS

The European dental bone graft substitute and other biomaterials market was valued at nearly €355 million in 2024. It is projected to grow at a compound annual growth rate of 3.4 percent to reach nearly €450 million in 2031.

This report covers dental bone graft substitutes (DBGSs), dental growth factors, dental barrier membranes (DBMs), local antimicrobial periodontal treatment, and dental soft tissue regeneration. Within DBGSs, the analysis includes allografts, xenografts, and synthetics, while autografts are excluded since they are harvested from the patient and are not sold commercially. The dental growth factor category includes sales of Straumann Group's Emdogain(R). The DBM market is split into resorbable and non-resorbable segments. Dental soft tissue regeneration is segmented into regenerative products and wound care products.

The market's trajectory reflects Europe's aging population, growing implant placement volumes, and broader awareness of regenerative dentistry among clinicians and patients. Demand is tempered by the region's stringent allograft protocols, continued use of autograft materials in selected countries, and gradual improvements in baseline oral health that reduce the long-term pool of fully edentulous patients. Even with these headwinds, steady adoption of xenograft and synthetic materials, plus expanding usage of barrier membranes and soft tissue products, is expected to support consistent market growth through 2031.

Market Overview

Regenerative dental materials are fundamental to modern implant and periodontal practice in Europe. DBGSs support socket preservation, sinus augmentation, ridge augmentation, and periodontal defect repair. Dental barrier membranes guide tissue regeneration and protect graft sites. Local antimicrobial periodontal treatments address residual bacterial burden, and soft tissue products promote closure and healing around implants and grafts.

The demand profile varies across Western, Northern, Central, and Southern Europe. Countries with mature implant markets and strong private-pay segments show higher penetration of xenografts and resorbable collagen membranes. In parallel, synthetic biomaterials remain important where cultural preferences limit animal-derived products or where procurement emphasizes cost stability. Allografts have grown in selected markets due to better processing techniques and quality assurance, though overall European uptake trails the United States because of regulation and tissue bank consolidation.

Aging demographics remain the dominant structural driver. By 2030, individuals 65 and older are expected to represent about a quarter of Europe's total population. Older adults experience higher rates of tooth loss, alveolar bone resorption, and periodontitis, which increases the need for grafting prior to implant placement. At the same time, widespread preventive dentistry and more routine hygiene compliance have improved dentition for many cohorts, which moderates long-run growth in fully edentulous cases. The net effect still favors steady expansion of regenerative procedures aligned with implants and complex periodontal therapy.

Market value reflects not only procedure volumes but also material mix, case complexity, and training intensity. Premium xenografts and resorbable membranes are used routinely in two-stage and immediate implant workflows. Synthetics add flexibility for practices that prefer non-animal materials or that need specific resorption profiles. Soft tissue products and wound care items support closure, especially in thin biotype cases and when clinicians need extra protection during early healing.

Market Drivers

Prevalence of oral disease

Global burden-of-disease analyses indicate large and rising totals of severe periodontitis and edentulism. In Western Europe, about 60 million people were living with severe periodontitis in 2021 with 5 million incident cases, and projections suggest a further rise in both prevalence and incidence by 2050. For edentulism, Western Europe reported 37 million cases in 2021, moving toward 48 million by 2050, with incidence also increasing over the same period. These burdens translate into sustained clinical demand for regenerative intervention, whether to preserve extraction sockets, build vertical or horizontal ridge volume, or stabilize soft tissues prior to definitive prosthetics.

Aging population

By 2030, people aged 65+ are expected to comprise about 25 percent of Europe's population. Age-related bone remodeling and the higher prevalence of systemic risk factors like diabetes and osteoporosis increase the likelihood of grafting before or during implant therapy. As a result, DBGSs and membranes will continue to be used at higher rates in older patients who want fixed restorations.

Greater consumer awareness and portfolio bundling

As implants gain popularity, implant vendors and distributors are bundling regenerative portfolios alongside implant lines. Dedicated sales teams and clinical education programs have raised awareness of guided bone regeneration and the role of membranes in predictable outcomes. This go-to-market model supports pull-through demand for xenografts, synthetics, and resorbable collagen membranes as standard adjuncts to implant placement.

Growing acceptance of allograft materials

Earlier concerns about disease transmission have eased as manufacturers implement validated processing, traceability, and quality assurance. With clearer messaging around safety and regulatory compliance, more clinicians are considering allograft options for specific defect types where handling and remodeling profiles fit their technique. Although allograft use remains lower than in the United States, acceptance is improving in centers with strong tissue bank partnerships and structured training.

Market Limiters

Improved oral health

Routine hygiene, fluoridation policies, and preventive care have reduced the long-term incidence of complete edentulism. As older cohorts retain more natural dentition, the absolute number of full-arch implant reconstructions and extensive ridge augmentations is moderated, even as single-tooth and segmental sites remain active.

Continued reliance on autograft materials

Autograft harvesting persists in parts of Europe, especially where surgeon preference and reimbursement frameworks favor intraoral donor sites. This is most evident in markets like France, where the DBGS segment is comparatively underdeveloped. Autograft usage displaces commercial DBGS demand in horizontal and vertical augmentation cases, limiting unit growth for allografts, xenografts, and synthetics.

Stringent allograft protocols and tissue bank consolidation

European regulation of human tissue products is strict. Over the last decade, tighter rules increased operating costs for tissue banks, leading to closures in several countries. In Portugal, for example, allograft distribution ceased when tissue banks could not reorganize under updated requirements. The result is a smaller pool of approved suppliers, constrained product choice, and an ongoing shift to autografts or cost-effective synthetics, which can cap average selling prices and dampen allograft penetration.

Price sensitivity in parts of Central and Southern Europe

Private-pay dynamics dominate many implant cases. In regions where out-of-pocket spending is high, clinicians may favor synthetic materials with attractive value profiles or limit membrane usage to the most clinically necessary cases. This keeps premium mix growth modest in price-sensitive markets.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that shape regenerative demand.
  • Time frame: Base year 2024, forecasts to 2031, historical data 2021-2023.
  • Data sources: Primary interviews with industry leaders, government and regulatory data, hospital and private practice inputs, import and export records, and the iData Research internal database.
  • Method note: Revenue modeled as units multiplied by ASP, validated with procedure counts, case mix, and distributor feedback.

Markets Covered and Segmentation

Dental Bone Graft Substitutes (DBGSs)

  • Type: Allografts, xenografts, synthetics
  • Application: Socket preservation, sinus augmentation, ridge augmentation, periodontal application

Dental Growth Factor

Includes Emdogain(R) sales

Dental Barrier Membranes (DBMs)

  • Type: Resorbable membranes, non-resorbable membranes

Local Antimicrobial Periodontal Treatment

Dental Soft Tissue Wound Care

  • Type: Regeneration products, dental wound care products such as plug, tape, and foam

For every segment, the report presents market values, unit sales, ASPs, growth rates, and company shares, with historical data to 2021 and forecasts to 2031.

Competitive Analysis

Geistlich remained the leading competitor in the total European DBGS and biomaterials market in 2024. Its dominance stems from leadership in both the DBGS and DBM segments. In DBGS, Geistlich holds a majority share in xenografts, supported by the well-established Bio-Oss(R) product line. In membranes, Bio-Gide(R) is widely used as a resorbable collagen barrier due to its handling, biocompatibility, and remodeling behavior. The brand's clinical legacy, training footprint, and long record of documentation continue to reinforce preference among periodontists and implant surgeons.

botiss biomaterials held the second-largest share of the total market in 2024. A key strength is its strategic partnership with Straumann Group, which holds a 30 percent stake in botiss. This relationship aligns botiss regenerative products with Straumann's leadership in implants across Europe, improving access and co-selling effectiveness. Flagship products include cerabone(R) (xenograft) and maxgraft(R) (allograft), which give clinicians a portfolio that spans material preferences and indications.

PerioChip(R) was the leading competitor in the European local antimicrobial periodontal treatment market in 2024, placing third overall in the total DBGS and biomaterials landscape. Distribution is supported by an extensive network. In Europe, Dexcel Pharma markets PerioChip(R) through subsidiaries and partners in Germany, the U.K., Benelux, Austria, and other countries. Additional distribution is provided by Curaden Healthcare in Italy and Karr Denta in Switzerland. PerioChip(R)'s role in reducing bacterial load within periodontal pockets complements regenerative and maintenance protocols, which helps anchor its adoption across specialist practices.

Other regional and local suppliers compete in synthetic DBGS, non-resorbable membranes, and selected soft tissue products. However, the market remains concentrated around companies that can support education, clinical evidence, and reliable logistics across multiple European countries with different regulatory expectations.

Technology and Practice Trends

  • Material choice by indication: Clinicians often combine xenografts for space maintenance with allografts or synthetics for remodeling speed, depending on case goals and timing for implant placement.
  • Shift to resorbable membranes: Resorbable collagen membranes remain the first choice for most GBR procedures due to ease of use and avoidance of removal surgery. Non-resorbable membranes retain a role in complex vertical augmentation when stronger space maintenance is needed.
  • Barrier fixation and stability: Tack systems, suturing techniques, and contouring advances reduce micromotion, improve soft tissue management, and increase predictability in challenging defects.
  • Soft tissue emphasis: Greater attention to thickening peri-implant soft tissue has increased the use of soft tissue graft substitutes and wound care materials in thin biotype patients or when harvesting autogenous connective tissue is not preferred.
  • Training, digital planning, and workflows: Digital planning tools and education programs emphasize defect classification, graft selection, and timing. Consistent protocols allow multi-site organizations and referral networks to standardize outcomes.
  • Quality systems and traceability: Documentation, batch tracking, and sterility assurance support clinician confidence and compliance with national guidelines, especially in allograft use.

Geography

The analysis covers the European Union.

Why This Report

Where are the largest and fastest-growing opportunities across xenografts, allografts, synthetics, barrier membranes, and soft tissue products.

How the aging population and oral disease burden will shape procedure demand through 2031.

How stringent allograft regulations and tissue bank consolidation affect product access and pricing in different European markets.

Which education and portfolio bundling strategies are most effective for implant and regenerative pull-through.

How leaders such as Geistlich, botiss biomaterials, and PerioChip(R) are positioned, and what their portfolios imply for competition in DBGS and membranes.

Where autograft reliance will continue to limit DBGS adoption, and how synthetics and targeted membrane selection can bridge clinical needs.

What technology and workflow trends will improve predictability in vertical and horizontal augmentation, socket preservation, and soft tissue management.

How to align training, inventory, and case documentation to standardize results across multi-site practices and referral networks.

The European Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail. Use it to quantify demand, plan portfolio strategy, guide regional market entry, and prioritize education that supports predictable regenerative outcomes.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

European Dental Bone Graft Substitute And Other Biomaterials Market Overview

Competitive Analysis

Market Developments

Market Trends

Procedure Segmentation

Market Segmentation

Key Report Updates

Version History

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

European Dental Bone Graft Substitute And Other Biomaterials Market Overview

  • 3.1 Introduction
    • 3.1.1 Applications Of Dental Bone Graft Substitutes
      • 3.1.1.1 Dental Implant Procedures
      • 3.1.1.2 Periodontal Procedures
    • 3.1.2 Types Of Dental Bone Graft Substitutes
      • 3.1.2.1 Allografts
      • 3.1.2.2 Demineralized Bone Matrix Allografts
      • 3.1.2.3 Xenografts
      • 3.1.2.4 Synthetics
    • 3.1.3 Dental Growth Factor Products
    • 3.1.4 Dental Membranes
    • 3.1.5 Antimicrobial Periodontal Treatment
    • 3.1.6 Dental Soft Tissue Regeneration
  • 3.2 Currency Exchange Rate
  • 3.3 Market Overview & Trend Analysis
  • 3.4 Drivers And Limiters
    • 3.4.1 Market Drivers
    • 3.4.2 Market Limiters
  • 3.5 Competitive Market Share Analysis
  • 3.6 Mergers And Acquisitions

Country Profiles

  • 4.1 Introduction
    • 4.1.1 Population
    • 4.1.2 Gdp Per Capita
    • 4.1.3 Price Index
  • 4.2 Germany
  • 4.3 France
  • 4.4 United Kingdom
  • 4.5 Italy
  • 4.6 Spain
  • 4.7 Benelux
  • 4.8 Scandinavia
  • 4.9 Austria
  • 4.10 Switzerland
  • 4.11 Portugal

Procedure Numbers

  • 5.1 Europe Tooth Loss Statistics
    • 5.1.1 Dental Bone Grafting Procedures
    • 5.1.2 Dental Implant Procedures And Dbgs Penetration Rates
    • 5.1.3 Dental Bone Grafting Procedures By Application

Dental Bone Graft Substitute Market

  • 6.1 Introduction
    • 6.1.1 Autografts
    • 6.1.2 Allografts
      • 6.1.2.1 Mineralized Allografts
      • 6.1.2.2 Demineralized Bone Matrix Allografts
    • 6.1.3 Xenografts
    • 6.1.4 Synthetics
  • 6.2 Market Overview
  • 6.3 Market Analysis And Forecast
    • 6.3.1 Total Dental Bone Graft Substitute Market
    • 6.3.2 Allograft Market By Segment
      • 6.3.2.1 Mineralized Allograft Market
      • 6.3.2.2 Demineralized Bone Matrix Allograft Market
    • 6.3.3 Xenograft Market
    • 6.3.4 Synthetic Market
    • 6.3.5 Dental Bone Graft Substitute Unit Sales By Procedure Type
      • 6.3.5.1 Socket Preservation
      • 6.3.5.2 Sinus Augmentation
      • 6.3.5.3 Ridge Augmentation
      • 6.3.5.4 Periodontal Application
  • 6.4 Drivers And Limiters
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 Competitive Market Share Analysis

Dental Growth Factor Market

  • 7.1 Introduction
  • 7.2 Market Analysis And Forecast
  • 7.3 Drivers And Limiters
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters

Dental Barrier Membrane Market

  • 8.1 Introduction
  • 8.2 Market Overview
  • 8.3 Market Analysis And Forecast
    • 8.3.1 Total Dental Barrier Membrane Market
    • 8.3.2 Resorbable Dental Barrier Membrane Market
    • 8.3.3 Non-Resorbable Dental Barrier Membrane Market
  • 8.4 Unit Analysis
    • 8.4.1 Dental Barrier Membrane Units Sold By Size
      • 8.4.1.1 Resorbable Dental Barrier Membrane Units Sold By Size
      • 8.4.1.2 Non-Resorbable Dental Barrier Membrane Units Sold By Size
  • 8.5 Drivers And Limiters
    • 8.5.1 Market Drivers
    • 8.5.2 Market Limiters
  • 8.6 Competitive Market Share Analysis

Local Antimicrobial Periodontal Treatment Market

  • 9.1 Introduction
  • 9.2 Market Analysis And Forecast
  • 9.3 Drivers And Limiters
    • 9.3.1 Market Drivers
    • 9.3.2 Market Limiters
  • 9.4 Competitive Market Share Analysis

Dental Soft Tissue Regeneration Market

  • 10.1 Introduction
  • 10.2 Market Overview
  • 10.3 Market Analysis And Forecast
    • 10.3.1 Dental Soft Tissue Regeneration Market
    • 10.3.2 Dental Wound Care Market
      • 10.3.2.1 Plug Dental Wound Care Market
      • 10.3.2.2 Tape Dental Wound Care Market
      • 10.3.2.3 Foam Dental Wound Care Market
  • 10.4 Drivers And Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe, 2024 - 2031
  • Chart 1-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, Europe, 2024 & 2031
  • Chart 3-1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe, 2021 - 2031
  • Chart 3-2: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, Europe, 2024
  • Chart 4-1: Country Profile, Germany, 2024
  • Chart 4-2: Country Profile, France, 2024
  • Chart 4-3: Country Profile, United Kingdom, 2024
  • Chart 4-4: Country Profile, Italy, 2024
  • Chart 4-5: Country Profile, Spain, 2024
  • Chart 4-6: Country Profile, Benelux, 2024
  • Chart 4-7: Country Profile, Scandinavia, 2024
  • Chart 4-8: Country Profile, Austria, 2024
  • Chart 4-9: Country Profile, Switzerland, 2024
  • Chart 4-10: Country Profile, Portugal, 2024
  • Chart 5-1: Dental Implants Placed with Dental Bone Grafting Substitute, Europe, 2021 - 2031
  • Chart 6-1: Dental Bone Graft Substitute Market by Segment, Europe, 2021 - 2031
  • Chart 6-2: Leading Competitors, Dental Bone Graft Substitute Market, Europe, 2024
  • Chart 7-1: Dental Growth Factor Market, Europe, 2021 - 2031
  • Chart 8-1: Dental Barrier Membrane Market by Segment, Europe, 2021 - 2031
  • Chart 8-2: Leading Competitors, Dental Barrier Membrane Market, Europe, 2024
  • Chart 9-1: Local Antimicrobial Periodontal Treatment Market, Europe, 2021 - 2031
  • Chart 9-2: Leading Competitors, Local Antimicrobial Periodontal Treatment Market, Europe, 2024
  • Chart 10-1: Dental Barrier Membrane Market by Segment, Europe, 2021 - 2031
  • Chart 10-2: Leading Competitors, Dental Soft Tissue Regeneration Market, Europe, 2024

LIST OF FIGURES

  • Figure 1-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, Europe, 2024
  • Figure 1-2: Companies Researched in This Report
  • Figure 1-3: Recent Events in the Dental Bone Graft Substitute and Other Biomaterials Market, Europe, 2021 - 2025 (1 of 3)
  • Figure 1-4: Recent Events in the Dental Bone Graft Substitute and Other Biomaterials Market, Europe, 2021 - 2025 (2 of 3)
  • Figure 1-5: Recent Events in the Dental Bone Graft Substitute and Other Biomaterials Market, Europe, 2021 - 2025 (3 of 3)
  • Figure 1-6: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe
  • Figure 1-7: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation
  • Figure 1-8: Dental Bone Graft and Other Biomaterials Market Segmentation
  • Figure 1-9: Key Report Updates
  • Figure 1-10: Version History
  • Figure 3-1: Currency Exchange Rate, 2024
  • Figure 3-2: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe, 2021 - 2031 (€M)
  • Figure 3-3: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe, 2021 - 2031 (US$M)
  • Figure 3-4: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, Europe, 2024
  • Figure 5-1: Dental Bone Grafting Procedure Penetration Rate, Europe, 2021 - 2031
  • Figure 5-2: Dental Bone Grafting Procedures by Application, Europe, 2021 - 2031
  • Figure 5-3: Socket Preservation Procedures by Country, Europe, 2021 - 2031
  • Figure 5-4: Sinus Augmentation Procedures by Country, Europe, 2021 - 2031
  • Figure 5-5: Ridge Augmentation Procedures by Country, Europe, 2021 - 2031
  • Figure 5-6: Periodontal Procedures Done with DBGS by Country, Europe, 2021 - 2031
  • Figure 6-1: Dental Bone Graft Substitute Market by Segment, Europe, 2021 - 2031 (€M)
  • Figure 6-2: Dental Bone Graft Substitute Market by Segment, Europe, 2021 - 2031 (US$M)
  • Figure 6-3: Dental Bone Graft Substitute Market, Europe, 2021 - 2031
  • Figure 6-4: Units Sold by Country, Dental Bone Graft Substitute Market, Europe, 2021 - 2031
  • Figure 6-5: Average Selling Price by Country, Dental Bone Graft Substitute Market, Europe, 2021 - 2031 (€)
  • Figure 6-6: Average Selling Price by Country, Dental Bone Graft Substitute Market, Europe, 2021 - 2031 (US$)
  • Figure 6-7: Market Value by Country, Dental Bone Graft Substitute Market, Europe, 2021 - 2031 (€M)
  • Figure 6-8: Market Value by Country, Dental Bone Graft Substitute Market, Europe, 2021 - 2031 (US$M)
  • Figure 6-9: Allograft Market by Segment, Europe, 2021 - 2031 (€M)
  • Figure 6-10: Allograft Market by Segment, Europe, 2021 - 2031 (US$M)
  • Figure 6-11: Total Allograft Market, Europe, 2021 - 2031
  • Figure 6-12: Units Sold by Country, Total Allograft Market, Europe, 2021 - 2031
  • Figure 6-13: Average Selling Price by Country, Total Allograft Market, Europe, 2021 - 2031 (€)
  • Figure 6-14: Average Selling Price by Country, Total Allograft Market, Europe, 2021 - 2031 (US$)
  • Figure 6-15: Market Value by Country, Total Allograft Market, Europe, 2021 - 2031 (€M)
  • Figure 6-16: Market Value by Country, Total Allograft Market, Europe, 2021 - 2031 (US$M)
  • Figure 6-17: Mineralized Allograft Market, Europe, 2021 - 2031
  • Figure 6-18: Units Sold by Country, Mineralized Allograft Market, Europe, 2021 - 2031
  • Figure 6-19: Average Selling Price by Country, Mineralized Allograft Market, Europe, 2021 - 2031 (€)
  • Figure 6-20: Average Selling Price by Country, Mineralized Allograft Market, Europe, 2021 - 2031 (US$)
  • Figure 6-21: Market Value by Country, Mineralized Allograft Market, Europe, 2021 - 2031 (€M)
  • Figure 6-22: Market Value by Country, Mineralized Allograft Market, Europe, 2021 - 2031 (US$M)
  • Figure 6-23: Demineralized Bone Matrix Allograft Market, Europe, 2021 - 2031
  • Figure 6-24: Units Sold by Country, Demineralized Bone Matrix Allograft Market, Europe, 2021 - 2031
  • Figure 6-25: Average Selling Price by Country, Demineralized Bone Matrix Allograft Market, Europe, 2021 - 2031 (€)
  • Figure 6-26: Average Selling Price by Country, Demineralized Bone Matrix Allograft Market, Europe, 2021 - 2031 (US$)
  • Figure 6-27: Market Value by Country, Demineralized Bone Matrix Allograft Market, Europe, 2021 - 2031 (€M)
  • Figure 6-28: Market Value by Country, Demineralized Bone Matrix Allograft Market, Europe, 2021 - 2031 (US$M)
  • Figure 6-29: Xenograft Market, Europe, 2021 - 2031
  • Figure 6-30: Units Sold by Country, Xenograft Market, Europe, 2021 - 2031
  • Figure 6-31: Average Selling Price by Country, Xenograft Market, Europe, 2021 - 2031 (€)
  • Figure 6-32: Average Selling Price by Country, Xenograft Market, Europe, 2021 - 2031 (US$)
  • Figure 6-33: Market Value by Country, Xenograft Market, Europe, 2021 - 2031 (€M)
  • Figure 6-34: Market Value by Country, Xenograft Market, Europe, 2021 - 2031 (US$M)
  • Figure 6-35: Synthetic Market, Europe, 2021 - 2031
  • Figure 6-36: Units Sold by Country, Synthetic Market, Europe, 2021 - 2031
  • Figure 6-37: Average Selling Price by Country, Synthetic Market, Europe, 2021 - 2031 (€)
  • Figure 6-38: Average Selling Price by Country, Synthetic Market, Europe, 2021 - 2031 (US$)
  • Figure 6-39: Market Value by Country, Synthetic Market, Europe, 2021 - 2031 (€M)
  • Figure 6-40: Market Value by Country, Synthetic Market, Europe, 2021 - 2031 (US$M)
  • Figure 6-41: DBGS Units Sold by Application, Europe, 2021 - 2031
  • Figure 6-42: DBGS Units Sold by Country, Socket Preservation, Europe, 2021 - 2031
  • Figure 6-43: DBGS Units Sold by Country, Sinus Augmentation, Europe, 2021 - 2031
  • Figure 6-44: DBGS Units Sold by Country, Ridge Augmentation, Europe, 2021 - 2031
  • Figure 6-45: DBGS Units Sold by Country, Periodontal Application, Europe, 2021 - 2031
  • Figure 6-46: Leading Competitors, Dental Bone Graft Substitute Market, Europe, 2024
  • Figure 6-47: Leading Competitors by Country, Dental Bone Graft Substitute Market, Europe, 2024
  • Figure 7-1: Dental Growth Factor Market, Europe, 2021 - 2031
  • Figure 7-2: Units Sold by Country, Dental Growth Factor Market, Europe, 2021 - 2031
  • Figure 7-3: Average Selling Price by Country, Dental Growth Factor Market, Europe, 2021 - 2031 (€)
  • Figure 7-4: Average Selling Price by Country, Dental Growth Factor Market, Europe, 2021 - 2031 (US$)
  • Figure 7-5: Market Value by Country, Dental Growth Factor Market, Europe, 2021 - 2031 (€M)
  • Figure 7-6: Market Value by Country, Dental Growth Factor Market, Europe, 2021 - 2031 (US$M)
  • Figure 8-1: Dental Barrier Membrane Market by Segment, Europe, 2021 - 2031 (€M)
  • Figure 8-2: Dental Barrier Membrane Market by Segment, Europe, 2021 - 2031 (US$M)
  • Figure 8-3: Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-4: Units Sold by Country, Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-5: Average Selling Price by Country, Dental Barrier Membrane Market, Europe, 2021 - 2031 (€)
  • Figure 8-6: Average Selling Price by Country, Dental Barrier Membrane Market, Europe, 2021 - 2031 (US$)
  • Figure 8-7: Market Value by Country, Dental Barrier Membrane Market, Europe, 2021 - 2031 (€M)
  • Figure 8-8: Market Value by Country, Dental Barrier Membrane Market, Europe, 2021 - 2031 (US$M)
  • Figure 8-9: Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-10: Units Sold by Country, Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-11: Average Selling Price by Country, Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (€)
  • Figure 8-12: Average Selling Price by Country, Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (US$)
  • Figure 8-13: Market Value by Country, Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (€M)
  • Figure 8-14: Market Value by Country, Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (US$M)
  • Figure 8-15: Non-Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-16: Units Sold by Country, Non-Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-17: Average Selling Price by Country, Non-Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (€)
  • Figure 8-18: Average Selling Price by Country, Non-Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (US$)
  • Figure 8-19: Market Value by Country, Non-Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (€M)
  • Figure 8-20: Market Value by Country, Non-Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031 (US$M)
  • Figure 8-21: Resorbable Dental Barrier Membrane Market by Size, Europe, 2021 - 2031
  • Figure 8-22: Units Sold by Country, Small Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-23: Units Sold by Country, Medium Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-24: Units Sold by Country, Large Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-25: Non-Resorbable Dental Barrier Membrane Market by Size, Europe, 2021 - 2031
  • Figure 8-26: Units Sold by Country, Small Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-27: Units Sold by Country, Medium Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-28: Units Sold by Country, Large Resorbable Dental Barrier Membrane Market, Europe, 2021 - 2031
  • Figure 8-29: Leading Competitors, Dental Barrier Membrane Market, Europe, 2024
  • Figure 9-1: Local Antimicrobial Periodontal Treatment Market, Europe, 2021 - 2031
  • Figure 9-2: Leading Competitors, Local Antimicrobial Periodontal Treatment Market, Europe, 2024
  • Figure 10-1: Total Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031
  • Figure 10-2: Dental Soft Tissue Regeneration Market by Segment, Europe, 2021 - 2031 (€M)
  • Figure 10-3: Dental Soft Tissue Regeneration Market by Segment, Europe, 2021 - 2031 (US$M)
  • Figure 10-4: Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031
  • Figure 10-5: Units Sold by Country, Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031
  • Figure 10-6: Average Selling Price by Country, Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031 (€)
  • Figure 10-7: Average Selling Price by Country, Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031 (US$)
  • Figure 10-8: Market Value by Country, Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031 (€M)
  • Figure 10-9: Market Value by Country, Dental Soft Tissue Regeneration Market, Europe, 2021 - 2031 (US$M)
  • Figure 10-10: Dental Wound Care Market by Segment, Europe, 2021 - 2031 (€M)
  • Figure 10-11: Dental Wound Care Market by Segment, Europe, 2021 - 2031 (US$M)
  • Figure 10-12: Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-13: Plug Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-14: Units Sold by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-15: Average Selling Price by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (€)
  • Figure 10-16: Average Selling Price by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (US$)
  • Figure 10-17: Market Value by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (€M)
  • Figure 10-18: Market Value by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (US$M)
  • Figure 10-19: Tape Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-20: Units Sold by Country, Tape Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-21: Average Selling Price by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (€)
  • Figure 10-22: Average Selling Price by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (US$)
  • Figure 10-23: Market Value by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (€M)
  • Figure 10-24: Market Value by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (US$M)
  • Figure 10-25: Foam Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-26: Units Sold by Country, Foam Dental Wound Care Market, Europe, 2021 - 2031
  • Figure 10-27: Average Selling Price by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (€)
  • Figure 10-28: Average Selling Price by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (US$)
  • Figure 10-29: Market Value by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (€M)
  • Figure 10-30: Market Value by Country, Plug Dental Wound Care Market, Europe, 2021 - 2031 (US$M)
  • Figure 10-31: Leading Competitors, Dental Soft Tissue Regeneration Market, Europe, 2024